Cartesian Growth Corporation II (RENE) Research

Cartesian Growth Corporation II's principal aim is to engage in strategic corporate transactions, such as mergers, share exchanges, asset acquisitions, equity purchases, reorganizations, or other comparable business integrations with various companies or entities. This firm was established in 2021 and maintains its headquarters in New York, New York.

Market snapshot

Symbol
RENE
Price
$11.75
Day change
0.00%
Market cap
$165.2M
P/E ratio
38.24x
52-week range
11.05-11.95
Sector
Financial Services
Industry
Shell Companies

Peer companies

  • Blockchain Coinvestors Acquisition Corp. I (BCSA)
  • Battery Future Acquisition Corp. (BFAC)
  • HH&L Acquisition Co. (HHLA)
  • SeaStar Medical Holding Corporation (ICU)
  • LAVA Medtech Acquisition Corp. (LVAC)
  • M3-Brigade Acquisition II Corp. (MBAC)
  • Enphys Acquisition Corp. (NFYS)
  • Ross Acquisition Corp II (ROSS)

Open Cartesian Growth Corporation II (RENE) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.